TransCode Therapeutics To Participate at MedInvest Oncology Investor Conference

NEXT STORY
Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC
PREV STORY
Yamana Gold Receives Permit at Jacobina, Initiating Ramp Up of Phase 2 Expansion, Expects Fourth Quarter Company Wide Production to Exceed 270,000 GEO With Costs Tracking to Be the Lowest of the Year
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Lyme Disease (LD): Global Market Insights, Epidemiology and Forecast to 2027

Dublin, Dec. 10, 2018 (GLOBE NEWSWIRE) -- The "Lyme Disease (LD)- Market Insights, Epidemiology ...

author_avatar
NASDAQ Market News

VBL Therapeutics Announces Top-Line Results from Pivotal Phase 3 GLOBE Study in Patients with Recurrent Glioblastoma

Conference Call and Webcast @ 8:30am ET Today TEL AVIV, Israel, March 08, 2018 ...

author_avatar
NASDAQ Market News

Atara Bio Announces First Quarter 2016 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., May 05, 2016 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), ...

author_avatar
NASDAQ Market News